targeted therapy
Showing 9951 - 9975 of >10,000
Diabetes, Type 2 Trial in Canada, United States (CGM, SMBG)
Completed
- Diabetes Mellitus, Type 2
- CGM
- SMBG
-
Huntington Beach, California
- +9 more
Mar 18, 2021
Pathogenic Metagenomic Next-generation Sequencing to Optimize
Recruiting
- Cirrhosis, Liver
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Sep 10, 2023
Dysfunctional Voiding Trial in Istanbul (Exercise, Standard therapy)
Completed
- Dysfunctional Voiding
- Exercise
- Standard therapy
-
Istanbul, TurkeyHaliƧ University
Sep 13, 2023
Diffuse Large B-cell Lymphoma Trial in Tampa, Philadelphia (Tisagenlecleucel, Ibrutinib)
Terminated
- Diffuse Large B-cell Lymphoma
- Tisagenlecleucel
- Ibrutinib
-
Tampa, Florida
- +1 more
Jan 27, 2023
Alcohol Drinking, Alcohol; Harmful Use Trial in Providence (Brief Motivational Interview)
Enrolling by invitation
- Alcohol Drinking
- Alcohol; Harmful Use
- Brief Motivational Interview
-
Providence, Rhode IslandBrown University
Jul 29, 2021
Ulcerative Colitis Trial in Worldwide (Mirikizumab, Placebo)
HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)
Recruiting
- HNSCC
- +4 more
- blood draws
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Iron Therapy in Erythropoietic Protoporphyria
Not yet recruiting
- Erythropoietic Protoporphyria
- Iron-deficiency
- (no location specified)
Oct 7, 2022
Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Niraparib
- +2 more
-
Washington, District of Columbia
- +2 more
Apr 13, 2022
Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course
Recruiting
- Locally Advanced Rectal Cancer
- Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
- Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Apr 25, 2023
Moderate to Severe Ulcerative Colitis Trial in Worldwide (50 mg Induction/Chronic, 450 mg Induction/Chronic, 150 mg
Completed
- Moderate to Severe Ulcerative Colitis
- 50 mg Induction/Chronic
- +3 more
-
Dothan, Alabama
- +158 more
Nov 21, 2022
Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q, Stage IV Wilms Tumor Trial in Worldwide (drug,
Active, not recruiting
- Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
- Stage IV Wilms Tumor
- doxorubicin hydrochloride
- +6 more
-
Birmingham, Alabama
- +206 more
Mar 23, 2022
Sepsis, Bacterial Infections, Community-Acquired Infections Trial (Clinical Decision Support Algorithm for Empiric Antibiotics
Not yet recruiting
- Sepsis
- +3 more
- Clinical Decision Support Algorithm for Empiric Antibiotics in Sepsis
- (no location specified)
Oct 25, 2023
Aphasia, Stroke Trial (PICTURE-IT, CoDeLT)
Not yet recruiting
- Aphasia
- Stroke
- PICTURE-IT
- CoDeLT
- (no location specified)
Apr 25, 2023
Stroke, Cerebrovascular Accident, Hemiparesis Trial in Pittsburgh (Noninvasive neuromodulation via paired
Completed
- Stroke
- +4 more
- Stimulation
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 3, 2021
Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)
Not yet recruiting
- Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Nivolumab
- +2 more
- (no location specified)
Aug 10, 2022
Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)
Not yet recruiting
- Bronchiectasis
- +3 more
- (no location specified)
Sep 6, 2023
Exercise Induced Laryngeal Obstruction (EILO) Trial in Oslo (Norwegian psychomotor physiotherapy)
Completed
- Exercise Induced Laryngeal Obstruction (EILO)
- Norwegian psychomotor physiotherapy
-
Oslo, NorwayLiv-Jorunn Kolnes
Sep 9, 2023
Type 1 Diabetes, Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Not yet recruiting
- Type 1 Diabetes
- Diabetes
- LY3209590
- Insulin Degludec
-
Concord, California
- +86 more
Aug 17, 2022
Urinary Incontinence Trial in Cairo (Biofeedback training and Osteopathy procedure, Biofeedback training, Osteopathy procedure)
Recruiting
- Urinary Incontinence
- Biofeedback training and Osteopathy procedure
- +2 more
-
Cairo, EgyptHany Mohamed Elgohary
Jul 14, 2023
Periodontal Diseases, Chronic Periodontitis, Periodontal Pocket Trial in Japan (IQOS, Cigarette)
Completed
- Periodontal Diseases
- +5 more
- IQOS
- Cigarette
-
Futtsu, Chiba, Japan
- +25 more
Jan 26, 2023
Workplace Culture, Help-Seeking Behavior, Social Stigma Trial in Palo Alto (Popular-Opinion Leader-led encouragement during
Not yet recruiting
- Workplace Culture
- +3 more
- Popular-Opinion Leader-led encouragement during training meetings and informal conversation
-
Palo Alto, CaliforniaStanford Medicine
Aug 23, 2022